Hodges E, Dasmahapatra J, Smith J L, Quin C T, Lanham S, Krishna M T, Holgate S T, Frew A J
Wessex Immunology, Southampton General Hospital, UK.
Clin Exp Immunol. 1998 Jun;112(3):363-74. doi: 10.1046/j.1365-2249.1998.00611.x.
T cells are thought to play an important regulatory role in asthma, but little is known about the T cell repertoire of the human lung or whether asthma is associated with any specific repertoire changes. Flow cytometry and MoAbs to TCR VB (TCRBV) families were used to quantify bronchoalveolar lavage (BAL) and blood T cells from normal and atopic individuals. Clonality was then assessed by polymerase chain reaction (PCR) amplification of cDNA and gene scanning using consensus and family-specific TCRBV primers and confirmed by sequence analysis. In addition, blood and BAL T cell populations were studied pre- and post-allergen challenge in four patients with allergic asthma. The majority of TCRBV families detected in blood by MoAb staining were also represented in BAL. While differences between BAL and blood populations were evident in each individual studied, these differences were not consistent between individuals or between CD4+ and CD8+ T cell subpopulations. These results are in broad agreement with other published studies, but in contrast to previous work we found a consistent difference between TCRBV7 family usage in blood and BAL in all individuals studied, and a consistently increased proportion of CD4+ BAL T cells bearing BV5S2/3 in asthmatics only. After allergen challenge, the pattern of TCRBV gene usage was largely unchanged as judged by flow cytometry. Gene scanning of PCR products generated from consensus VB primers revealed polyclonal lymphocyte populations in blood and BAL from all seven atopic individuals: in one normal tested polyclonal populations were found in blood and oligoclonal populations in BAL. Selected families amplified with family-specific primers BV5S2/3, BV6 and BV7 (chosen because of their predominance in BAL compared with blood) were more variable and revealed predominant polyclonal populations in blood and polyclonal or oligoclonal populations in BAL. In one asthmatic patient a clonal BV5S2 family was found in BAL. Following allergen challenge there were no significant changes in polyclonality/oligoclonality/clonality in three cases, but in one case a clonal BV5S2 population was found after challenge, that had not been evident beforehand. The lung T cell repertoire is thus broadly representative of blood T cells, but shows population differences that may result from response to persistent exposure to airborne antigens common to normal and atopic individuals. Oligoclonal TCRBV family expansion appears to be primarily lung-specific but independent of atopic asthma, although our challenge data in one case support the concept that clonal populations may follow local allergen challenge. These data are consistent with selection and amplification of specific T cell families in the lung in response to local antigenic exposure.
T细胞被认为在哮喘中发挥重要的调节作用,但对于人类肺部的T细胞库,或者哮喘是否与任何特定的库变化相关,人们了解甚少。利用流式细胞术和针对TCR VB(TCRBV)家族的单克隆抗体(MoAbs)来定量正常个体和特应性个体的支气管肺泡灌洗(BAL)液及血液中的T细胞。然后通过聚合酶链反应(PCR)扩增cDNA并使用共有及家族特异性TCRBV引物进行基因扫描来评估克隆性,并通过序列分析加以证实。此外,对4例过敏性哮喘患者在过敏原激发前后的血液和BAL T细胞群体进行了研究。通过单克隆抗体染色在血液中检测到的大多数TCRBV家族在BAL液中也有体现。虽然在所研究的每个个体中BAL液和血液群体之间的差异很明显,但这些差异在个体之间或CD4 +和CD8 + T细胞亚群之间并不一致。这些结果与其他已发表的研究大致相符,但与之前的工作不同的是,我们发现在所有研究个体中,血液和BAL液中TCRBV7家族的使用存在一致的差异,并且仅在哮喘患者中,携带BV5S2 / 3的CD4 + BAL T细胞比例持续增加。过敏原激发后,通过流式细胞术判断,TCRBV基因的使用模式基本未变。从共有VB引物生成的PCR产物的基因扫描显示,所有7例特应性个体的血液和BAL液中的淋巴细胞群体均为多克隆:在1例正常受试者中,血液中发现多克隆群体,BAL液中发现寡克隆群体。用家族特异性引物BV5S2 / 3、BV6和BV7(因其在BAL液中相对于血液中占优势而选择)扩增的选定家族更具变异性,显示血液中主要为多克隆群体,BAL液中为多克隆或寡克隆群体。在1例哮喘患者的BAL液中发现了一个克隆性的BV5S2家族。过敏原激发后,3例患者的多克隆性/寡克隆性/克隆性没有明显变化,但在1例患者中,激发后发现了一个之前未出现的克隆性BV5S2群体。因此,肺部T细胞库在很大程度上代表了血液T细胞,但显示出群体差异,这可能是由于对正常个体和特应性个体常见的空气传播抗原持续暴露的反应所致。寡克隆TCRBV家族扩增似乎主要是肺部特异性的,但与特应性哮喘无关,尽管我们在1例患者中的激发数据支持克隆群体可能跟随局部过敏原激发的概念。这些数据与肺部中特定T细胞家族因局部抗原暴露而发生的选择和扩增一致。